I recently underwent genetic testing at Memorial Sloan Kettering under the supervision of Michael F Walsh a pediatric oncologist and geneticist at Sloan . An article published in NEJM in which Dr Walsh was a co-author demonstrated increased incidence of germline genetic mutations of those with advanced prostate cancer ( 11.8% ) versus localized prostate cancer ( 4.6 % ) . I would presume a possible benefit in the future for targeted therapies , clinical trials , and family generational considerations . I know that Nalakrats has informed of I believe foundation one genetic testing organization . Not making any recommendations , just informing .
Here are the link to the article : N Engl J Med 2016 ; 375:443-453
DOI: 10.1056/NEJMoa1603144
Edward